Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis.

Li, Dan; Fei, Fan; Yu, Hua; Huang, Xiangning; Long, Shanshan; Zhou, Hao; Zhang, Jie

Li, Dan; Fei, Fan; Yu, Hua; Huang, Xiangning; Long, Shanshan; Zhou, Hao; Zhang, Jie.

Afiliación

Li D; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Fei F; Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Yu H; Department of Laboratory Medicine, Medical Center Hospital of Qionglai City, Chengdu, China.
Huang X; Department of Neurosurgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Long S; Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Zhou H; Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Zhang J; Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Front Pharmacol ; 12: 707499, 2021.

Article en En | MEDLINE | ID: mdl-34594216

Palabras clave

carbapenem-resistant gram-negative pathogen; ceftazidime-avibactam therapy; combination therapy; efficacy; meta-analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google